EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Integrated bioinformatics approach reveals potential key genetic biomarkers and therapeutic targets in Alzheimer’s disease

Shreya Satyanarayan Bhat, Vidya Niranjan, Trilok Chandran Bodhireddy, Spoorthi R. Kulkarni, Spoorti Anil Bandikatte, C. Lavanya

NeuroMarkers · 2026-11 · 3 (4) · 100182

DOI: 10.1016/j.neumar.2026.100182 ↗

Kurz gefasst

Fachartikel in der Zeitschrift NeuroMarkers, 2026-11. Verfasst von Shreya Satyanarayan Bhat und 5 weiteren Autor:innen. Die Arbeit nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Alzheimer’s disease is a complex neurodegenerative disorder that necessitates integrative approaches to elucidate the mechanisms underlying disease-associated transcriptional dysregulation. The study aimed to explore disease-associated gene expression patterns, identify putative regulatory mechanisms, and contextualize these findings within known biological pathways relevant to Alzheimer’s disease.

Methods

We performed a comprehensive reanalysis of publicly available single-nucleus RNA sequencing data from the human cortex to explore disease-related gene expression patterns in Alzheimer’s disease within a cell-type–resolved framework.

Results

This approach revealed modest yet consistent transcriptional differences between Alzheimer’s disease and control samples, without evidence of widespread differential expression. Exploratory analyses highlighted genes and pathways associated with neuronal signaling, immune-related processes, and cellular stress responses, providing insight into disease-associated molecular trends. Network-based analyses further contextualized these findings within protein–protein interaction and regulatory frameworks. Given the limited number of biological samples, all results are interpreted as exploratory and hypothesis-generating rather than diagnostic in nature.

Conclusion

This integrative single-nucleus transcriptomic analysis provides a rigorously corrected and biologically informed perspective on transcriptional alterations in Alzheimer’s disease, offering a foundation for future validation studies and mechanistic investigations.

Zitieren

APA

Bhat, S. S., Niranjan, V., Bodhireddy, T. C., Kulkarni, S. R., Bandikatte, S. A., & Lavanya, C. (2026). Integrated bioinformatics approach reveals potential key genetic biomarkers and therapeutic targets in Alzheimer’s disease. NeuroMarkers, 3(4), 100182. https://doi.org/10.1016/j.neumar.2026.100182

Vancouver

Bhat SS, Niranjan V, Bodhireddy TC, Kulkarni SR, Bandikatte SA, Lavanya C. Integrated bioinformatics approach reveals potential key genetic biomarkers and therapeutic targets in Alzheimer’s disease. NeuroMarkers. 2026;3(4):100182. doi:10.1016/j.neumar.2026.100182

BibTeX
@article{Bhat2026,
  author = {Bhat, Shreya Satyanarayan and Niranjan, Vidya and Bodhireddy, Trilok Chandran and Kulkarni, Spoorthi R. and Bandikatte, Spoorti Anil and Lavanya, C.},
  title = {Integrated bioinformatics approach reveals potential key genetic biomarkers and therapeutic targets in Alzheimer’s disease},
  journal = {NeuroMarkers},
  year = {2026},
  volume = {3},
  number = {4},
  pages = {100182},
  doi = {10.1016/j.neumar.2026.100182}
}
Kostenlos starten →